Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,025 | -1,887 | -792 | -2,312 | -1,625 |
| Depreciation Amortization | 191 | 126 | 63 | 273 | 207 |
| Other Working Capital | 22 | -120 | 71 | -39 | -177 |
| Other Operating Activity | 481 | 450 | 126 | 163 | 135 |
| Operating Cash Flow | $-2,332 | $-1,431 | $-532 | $-1,914 | $-1,461 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | 10 | 27 | -10 | -10 |
| Investing Cash Flow | $-9 | $10 | $27 | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 53 | 69 | N/A | N/A | N/A |
| Common Stock Issued | 4,512 | 4,511 | 1,996 | 1,692 | 1,699 |
| Financing Cash Flow | $4,565 | $4,580 | $1,996 | $1,692 | $1,699 |
| Beginning Cash Position | 476 | 476 | 476 | 707 | 707 |
| End Cash Position | 2,700 | 3,634 | 1,967 | 476 | 936 |
| Net Cash Flow | $2,224 | $3,159 | $1,491 | $-232 | $228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,332 | -1,431 | -532 | -1,914 | -1,461 |
| Capital Expenditure | -51 | -18 | N/A | -13 | -10 |
| Free Cash Flow | -2,383 | -1,449 | -532 | -1,927 | -1,471 |